Baird lowered the firm’s price target on iRhythm to $94 from $102 and keeps an Outperform rating on the shares. The firm said they delivered another quarter of +20% top-line growth, though lower gross margin headwinds and higher OpEx, led to slight bottom-line miss.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IRTC:
- iRhythm sees FY23 revenue $487.5M-$490M, consensus $488.53M
- iRhythm reports Q3 EPS (89c), consensus (66c)
- iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
- iRhythm price target lowered to $100 from $138 at Truist
- iRhythm price target lowered to $135 from $149 at Morgan Stanley
